Pipeline

The development of our pipelines is introduced here.

SPP-005
Aminolevulinic acid hydrochloride

Photodynamic diagnosis to advanced gastric cancer with staging laparoscopy

Osaka University
(Provision to investigator-initiated trial)

Phase III

SPP-004
Combination of aminolevulinic acid hydrochloride and sodium ferrous citrate

Mitochondrial Disease

Saitama Medical University and National Center for Child Health and Development
(Provision to investigator-initiated trial)

Phase III

SPP-003
Combination of aminolevulinic acid hydrochloride and Sodium Ferrous Citrate

Renal function decline by cisplatin chemotherapy

Self-development

Phase II

Combination of aminolevulinic acid hydrochloride and Sodium Ferrous Citrate

Ischemia reperfusion injury

University of Oxford, University of Leicester, University of Birmingham & University of Cambridge
(Provision to investigator-initiated trial)

Under preparation

Combination of aminolevulinic acid hydrochloride and Sodium Ferrous Citrate

Brain tumor (interstitial photodynamic therapy)

University of Münster
(Provision to investigator-initiated trial)

Under preparation

Aminolevulinic acid hydrochloride

Cutaneous ulcer infected with methicillin-resistant Staphylococcus aureus (MRSA) and multidrug-resistant Pseudomonas aeruginosa

TBD

Under preparation

Aminolevulinic acid hydrochloride

Reinforcement of cancer radiotherapy

TBD

Under preparation

Aminolevulinic acid hydrochloride

photodynamic diagnosis of bladder cancer

TBD

Under preparation

Mechanical Translations by Google »